Why Astera Labs Stock Surged on Monday Investors were clearly looking forward to the company's earnings release after market close on Tuesday.
Provident Dumps 490,000 MapleBear Shares Worth $18 Million Maplebear Inc. connects North American households with personal shoppers through its technology-driven grocery delivery platform.
Could Sandisk Stock Be the Next Nvidia? Sandisk's sales and profits are soaring, and so too is the stock.
Amentum: An Intriguing Investment in the Defense Sector Is Amentum the next big opportunity in the defense sector? Join us as we explore its potential and the challenges it faces in the market.
Stock Market Today, Feb. 9: Oracle Rallies as AI Spending Reframes Its Cloud Growth Story Oracle moved higher as AI-related cloud spending strengthened confidence in its long-term expansion plans.
Why Microsoft Stock Topped the Market Today Several developments, including a bullish new analyst note, gave lift to the beaten-down software giant.
Stock Market Today, Feb. 9: TeraWulf Jumps After Morgan Stanley Initiates Coverage With Bullish AI View TeraWulf moved higher after Morgan Stanley initiated coverage and highlighted the company’s potential as an AI-focused data center operator, shifting attention away from bitcoin-only exposure.
Stock Market Today, Feb. 9: Transocean Shares Surge After Announcing $5.8 Billion Valaris Acquisition On Feb. 9, 2026, offshore drilling’s scale and backlog are being reshaped by a $5.8 billion all-stock merger.
What Roblox Needs to Prove in 2026 Roblox's strong 2025 reset raised expectations -- now execution matters.
Why Oracle Stock Popped Today The database leader is poised for a rebound.
Why Oklo Stock Popped Today This advanced nuclear reactor designer had no news to report. So what drove shares higher?
Microsoft Finally Revealed How Many Paying Copilot Customers It Has. The Answer Was Shocking for More Reasons Than One. For years, investors have tried to figure out how many users are actually paying for a product that is at the center of Microsoft's artificial intelligence strategy.
Why Did RGNX Shares Plummet 19% After-Hours Today? REGENXBIO said on Monday that the U.S. Food and Drug Administration (FDA) denied approval for its gene therapy in treating Hunter syndrome, outlining several reasons for the denial.
